ࡱ>  xPbjbjBrBr 7v  LH+Z Z 8t]$@tttJ@L@L@L@L@L@L@$CqFzp@tttttp@@V'V'V'tJ@V'tJ@V'V'3h 5DZe>"L46@@0@\4F$F 5 5> F^?ttV'tttttp@p@V'ttt@ttttFtttttttttZ c: Central Line-Associated Bloodstream Infections Fact Sheet Bottom line Central line-associated bloodstream infections (CLABSIs) result annually in: 84,551 to 203,916 preventable infections 10,426 to 25,145 preventable deaths $1.7 to $21.4 billion avoidable costs The following interventions decrease the risk for CLABSIs Use appropriate hand hygiene Use chlorhexidine for skin preparation Use full-barrier precautions during central venous catheter (CVC) insertion Avoid using the femoral vein for CVCs in adult patients Remove unnecessary CVCs Reference  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Umscheid%20CA%5BAuthor%5D&cauthor=true&cauthor_uid=21460463" Umscheid CA,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Mitchell%20MD%5BAuthor%5D&cauthor=true&cauthor_uid=21460463" Mitchell MD, et al. Estimating the proportion of reasonably preventable hospital-acquired infections and associated mortality and costs.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/21460463" \o "Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America." Infect Control Hosp Epidemiol. 2011 Feb;32(2):101-114. Our current performance Based on our current performance, our opportunity to improve the care that we provide to patients if we eliminated CLABSIs in our unit:* Current CLABSI rate: Deaths/year: Excess intensive care unit days/year: Excess dollars/year: *This data may be calculated using the CLABSI Opportunity Estimator at  HYPERLINK "http://www.hopkinsmedicine.org/quality_safety_research_group/our_projects/stop_bsi/toolkits_resources/clabsi_estimator.html" http://www.hopkinsmedicine.org/quality_safety_research_group/our_projects/stop_bsi/toolkits_resources/clabsi_estimator.html. The opportunity estimator uses current evidence from multiple studies, and the list of references can be found on the opportunity estimator Web site. The following information is from the 2008 Society for Healthcare Epidemiology of America and Infectious Disease Society of America Practice Recommendation: Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals. (Infect Control Hosp Epidemiol 2008;29:S22-S30.) Each recommendation is categorized on the basis of existing scientific data, theoretical rationale, applicability, and economic impact. Category A-I recommendations are strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies. Use appropriate hand hygiene Bottom line: Proper hand hygiene is required before and after palpating catheter insertion sites as well as before and after inserting, replacing, accessing, repairing, or dressing an intravascular catheter. In addition, the use of gloves does not obviate the need for hand hygiene. Category B-II Since 1977, at least seven prospective studies have shown that improvement in hand hygiene significantly decreases a variety of infectious complications. Proper hand hygiene procedures can be achieved through the use of either a waterless, alcohol-based product or antibacterial soap and water with adequate rinsing. Compared with peripheral venous catheters, CVCs carry a substantially greater risk for infection; therefore, the level of barrier precautions needed to prevent infection during insertion of CVCs should be more stringent than proper hand hygiene alone. References  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Pittet%20D%5BAuthor%5D&cauthor=true&cauthor_uid=11073019" Pittet D,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Hugonnet%20S%5BAuthor%5D&cauthor=true&cauthor_uid=11073019" Hugonnet S,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Harbarth%20S%5BAuthor%5D&cauthor=true&cauthor_uid=11073019" Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Pittet%20D%20Lancet%202000%3B356%3A1307-1309" \o "Lancet." Lancet. 2000 Oct 14;356(9238):1307-1312.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Larson%20EL%5BAuthor%5D&cauthor=true&cauthor_uid=7503437" Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed/7503437" \o "American journal of infection control." Am J Infect Control. 1995 Aug;23(4):251-269.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Rosenthal%20VD%5BAuthor%5D&cauthor=true&cauthor_uid=16153485" Rosenthal VD,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Guzman%20S%5BAuthor%5D&cauthor=true&cauthor_uid=16153485" Guzman S,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Safdar%20N%5BAuthor%5D&cauthor=true&cauthor_uid=16153485" Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Rosenthal%20VD%20Am%20J%20Infect%20Control%202005%3B33%3A392-397" \o "American journal of infection control." Am J Infect Control. 2005 Sep;33(7):392-397.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Boyce%20JM%5BAuthor%5D&cauthor=true&cauthor_uid=12418624" Boyce JM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Pittet%20D%5BAuthor%5D&cauthor=true&cauthor_uid=12418624" Pittet D;  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Healthcare%20Infection%20Control%20Practices%20Advisory%20Committee%5BCorporate%20Author%5D" Healthcare Infection Control Practices Advisory Committee;  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=HICPAC%2FSHEA%2FAPIC%2FIDSA%20Hand%20Hygiene%20Task%20Force%5BCorporate%20Author%5D" HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Boyce%20JM%20MMWR" \o "MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control." MMWR Recomm Rep. 2002 Oct 25;51(RR-16):1-45, quiz CE1-4.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Yilmaz%20G%5BAuthor%5D&cauthor=true&cauthor_uid=17595436" Yilmaz G,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Koksal%20I%5BAuthor%5D&cauthor=true&cauthor_uid=17595436" Koksal I,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Aydin%20K%5BAuthor%5D&cauthor=true&cauthor_uid=17595436" Aydin K, et al. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Yilmaz%20G%20JPEN%202007%3B31%3A284-287" \o "JPEN. Journal of parenteral and enteral nutrition." J Parenter Enteral Nutr. 2007 Jul-Aug;31(4):284-287. Use chlorhexidine for skin preparation Bottom line: Disinfect clean skin with an appropriate antiseptic before catheter insertion and during dressing changes. An alcoholic chlorhexidine solution containing a concentration greater than 0.5 percent is preferred. Category A-I In a study from 1991, preparation of central venous and arterial sites with a 2 percent aqueous chlorhexidine gluconate lowered blood stream infection rates compared with site preparation with 10 percent povidone-iodine or 70 percent alcohol. Since that time, there has been growing evidence that chlorhexidine-containing skin preparation is superior to other options. A meta-analysis from 2002 that pooled results of these studies demonstrated use of a chlorhexidine-containing preparation decreased central catheter-related infections by 49 percent relative to povidone-iodine preparations. Because a smaller effect of chlorhexidine was seen in studies using a 0.5 percent concentration of chlorhexidine, preparations with greater concentrations are recommended. References  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Maki%20DG%5BAuthor%5D&cauthor=true&cauthor_uid=1677698" Maki DG,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Ringer%20M%5BAuthor%5D&cauthor=true&cauthor_uid=1677698" Ringer M,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Alvarado%20CJ%5BAuthor%5D&cauthor=true&cauthor_uid=1677698" Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Maki%20DG%20%20Lancet%201991%3B338%3A339-343" \o "Lancet." Lancet. 1991 Aug 10;338(8763):339-343.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Chaiyakunapruk%20N%5BAuthor%5D&cauthor=true&cauthor_uid=12044127" Chaiyakunapruk N,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Veenstra%20DL%5BAuthor%5D&cauthor=true&cauthor_uid=12044127" Veenstra DL,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lipsky%20BA%5BAuthor%5D&cauthor=true&cauthor_uid=12044127" Lipsky BA, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Chaiyakunapruk%20N%20%20Ann%20Intern%20Med%202002%3B136%3A792-801" \o "Annals of internal medicine." Ann Intern Med. 2002 Jun 4;136(11):792-801.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Humar%20A%5BAuthor%5D&cauthor=true&cauthor_uid=11049783" Humar A,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Ostromecki%20A%5BAuthor%5D&cauthor=true&cauthor_uid=11049783" Ostromecki A,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Direnfeld%20J%5BAuthor%5D&cauthor=true&cauthor_uid=11049783" Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Humar%20A%20Clin%20Infect%20Dis%202000%3B31%3A1001-1007" \o "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America." Clin Infect Dis. 2000 Oct;31(4):1001-1007. Epub 2000 Oct 25. Use full-barrier precautions during CVC insertion Bottom line: Maintain aseptic technique for the insertion of intravascular catheters. Category A-I Maximal sterile barrier precautions (e.g., cap, mask, sterile gown, sterile gloves, and large sterile drape) during the insertion of CVCs substantially reduces the incidence of CLABSI compared with standard precautions (e.g., sterile gloves and small drapes). References  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Mermel%20LA%5BAuthor%5D&cauthor=true&cauthor_uid=1928165" Mermel LA,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=McCormick%20RD%5BAuthor%5D&cauthor=true&cauthor_uid=1928165" McCormick RD,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Springman%20SR%5BAuthor%5D&cauthor=true&cauthor_uid=1928165" Springman SR, et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Mermel%20LA%20Am%20J%20Med%201991%3B91(suppl)%3AS197%E2%80%93S205" \o "The American journal of medicine." Am J Med. 1991 Sep 16;91(3B):197S-205S.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Raad%20II%5BAuthor%5D&cauthor=true&cauthor_uid=8207189" Raad II,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Hohn%20DC%5BAuthor%5D&cauthor=true&cauthor_uid=8207189" Hohn DC,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Gilbreath%20BJ%5BAuthor%5D&cauthor=true&cauthor_uid=8207189" Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Raad%20II%20Infect%20Control%20Hosp%20Epidemiol%201994%3B15%3A231%E2%80%938" \o "Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America." Infect Control Hosp Epidemiol. 1994 Apr;15(4 Pt 1):231-238.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Hu%20KK%5BAuthor%5D&cauthor=true&cauthor_uid=15153925" Hu KK,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lipsky%20BA%5BAuthor%5D&cauthor=true&cauthor_uid=15153925" Lipsky BA,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Veenstra%20DL%5BAuthor%5D&cauthor=true&cauthor_uid=15153925" Veenstra DL, et al. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Hu%20KK%20et%20al.%20Am%20J%20Infect%20Control%202004%3B32%3A142-146" \o "American journal of infection control." Am J Infect Control. 2004 May;32(3):142-146.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Young%20EM%5BAuthor%5D&cauthor=true&cauthor_uid=17015155" Young EM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Commiskey%20ML%5BAuthor%5D&cauthor=true&cauthor_uid=17015155" Commiskey ML,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Wilson%20SJ%5BAuthor%5D&cauthor=true&cauthor_uid=17015155" Wilson SJ. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Young%20EM%20Am%20J%20Infect%20Control%202006%3B34%3A503-506" \o "American journal of infection control." Am J Infect Control. 2006 Oct;34(8):503-506. Avoid using the femoral vein for CVCs in adult patients Bottom line: Use of the femoral site is associated with greater risk of infection and deep venous thrombosis in adults. Category A-I The site at which a catheter is placed influences the subsequent risk for catheter-related infection and noninfectious complications. For adults, lower extremity insertion sites are associated with a higher risk for infection than are upper extremity sites. As a result, authorities recommend that the femoral vein be avoided. Place CVCs in an alternative site to reduce the risk for infection. The risk of noninfectious complications should be assessed on an individual basis when determining which site to place the CVC. References  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lorente%20L%5BAuthor%5D&cauthor=true&cauthor_uid=16280064" Lorente L,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Henry%20C%5BAuthor%5D&cauthor=true&cauthor_uid=16280064" Henry C,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Mart%C3%ADn%20MM%5BAuthor%5D&cauthor=true&cauthor_uid=16280064" Martn MM, et al. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lorente%20L%20Crit%20Care%202005%3B9%3AR631-R635" \o "Critical care (London, England)." Crit Care. 2005;9(6):R631-635. Epub 2005 Sep 28.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Merrer%20J%5BAuthor%5D&cauthor=true&cauthor_uid=11495620" Merrer J,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=De%20Jonghe%20B%5BAuthor%5D&cauthor=true&cauthor_uid=11495620" De Jonghe B,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Golliot%20F%5BAuthor%5D&cauthor=true&cauthor_uid=11495620" Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Merrer%20J%20JAMA%202001%3B286%3A700%E2%80%937." \o "JAMA : the journal of the American Medical Association." JAMA. 2001 Aug 8;286(6):700-707.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Goetz%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=9831940" Goetz AM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Wagener%20MM%5BAuthor%5D&cauthor=true&cauthor_uid=9831940" Wagener MM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Miller%20JM%5BAuthor%5D&cauthor=true&cauthor_uid=9831940" Miller JM, et al. Risk of infection due to central venous catheters: effect of site of placement and catheter type.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Goetz%20AM%20nfect%20Control%20Hosp%20Epidemiol%201998%3B19%3A842%E2%80%935.." \o "Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America." Infect Control Hosp Epidemiol. 1998 Nov;19(11):842-845. Remove unnecessary CVCs Bottom line: Promptly remove any intravascular catheter that is no longer essential. Category A-II One of the most effective strategies for preventing CLABSIs is to eliminate or at least reduce exposure to CVCs. The decision regarding the need for a catheter is complex, however, and difficult to standardize into a practice guideline. Nonetheless, to reduce exposure to CVCs, the multidisciplinary team should adopt a strategy to systematically evaluate daily whether any catheters or tubes can be removed. References  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lederle%20FA%5BAuthor%5D&cauthor=true&cauthor_uid=1558345" Lederle FA,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Parenti%20CM%5BAuthor%5D&cauthor=true&cauthor_uid=1558345" Parenti CM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Berskow%20LC%5BAuthor%5D&cauthor=true&cauthor_uid=1558345" Berskow LC, et al. The idle intravenous catheter.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lederle%20FA%20Ann%20Intern%20Med%201992%3B116%3A737-738" \o "Annals of internal medicine." Ann Intern Med. 1992 May 1;116(9):737-738.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Parenti%20CM%5BAuthor%5D&cauthor=true&cauthor_uid=8053750" Parenti CM,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Lederle%20FA%5BAuthor%5D&cauthor=true&cauthor_uid=8053750" Lederle FA,  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Impola%20CL%5BAuthor%5D&cauthor=true&cauthor_uid=8053750" Impola CL, et al. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project.  HYPERLINK "http://www.ncbi.nlm.nih.gov/pubmed?term=Parenti%20CM%20Arch%20Intern%20Med%201994%3B154%3A1829-1832" \o "Archives of internal medicine." Arch Intern Med. 1994 Aug 22;154(16):1829-1832.      PAGE \* MERGEFORMAT 4   ./:BFtuv}~@ E _ `    + ,   * ݱݱݱݱwwwww hsfch?CJOJPJQJaJ)jhsfch?CJOJPJQJUaJh?h?5OJQJh4OJQJhwhr/OJQJh? h$^h?h?h?OJQJh?hr/OJQJh?OJQJhMhsfc_H hMh?_H hMh S T a b gdsfc & Fgd?gd? & Fgd?gd?hgdsfcgdM* + - c d 6 : ; < b | pqٺȯzgXghwhaCJOJQJaJ%jhwhaCJOJQJUaJhwhECJOJQJaJh?OJQJh,OJQJhwhEOJQJh?h?OJQJh?hr/OJQJh4CJOJPJQJaJ hsfchr/CJOJPJQJaJ hsfch?CJOJPJQJaJ)jhsfch?CJOJPJQJUaJ MNYA  ##$'''H*-J0|0gdYBd7$8$H$gdwgd.gd?hgdsfcgd. dgdwq ;e{|~rs;Ͳ;ͦ͗yymbVh`th`t5OJQJh?h?OJQJh4OJQJmH sH h4OJQJh?hnNOJQJh?hwOJQJhwhECJOJQJaJh?CJOJQJaJh#CJOJQJaJhwh#CJOJQJaJhwhaCJOJQJaJ%jhwhaCJOJQJUaJ hwha0JCJOJQJaJ ab.noij|MNQXYZEFPQSTJK h.h`tCJOJPJQJaJ)jh.h`tCJOJPJQJUaJhMe(hMe(5OJQJhMe(hw5OJQJh#OJQJh`tOJQJh?hOJQJh?hwOJQJh`thw5OJQJ8TU^_'(<=AB34<=?@9:  z{Z[ )jh.h`tCJOJPJQJUaJ h.hMe(CJOJPJQJaJ h.h`tCJOJPJQJaJI N!O!W!X!Z![!!!!!!!C"D"K"L"""L#M#e#f#~###########$$R$y$$$ %ٷ}rjjhMe(OJQJh?hOJQJhMe(h95OJQJhMe(hw5OJQJh?hwOJQJh4OJQJmH sH h?h?OJQJ h.hCJOJPJQJaJ h.hMe(CJOJPJQJaJ h.h5xCJOJPJQJaJ)jh.h5xCJOJPJQJUaJ) % %%,%X%a%v%%%%&&&&&&&''/'7'q'r'''''' ( ((((((((((()) ))))* *'*(*H*ż hYBh.CJOJPJQJaJ)jhYBh.CJOJPJQJUaJh.hw5OJQJh.5OJQJhd%hOJQJ^Jh.OJQJh#OJQJhMe(OJQJh?hwOJQJh?hOJQJ2H*I*******E+F+Q+R+T+U+++++?,@,,,,,--u-v-}-~-----....u.v...2/3/ 0 0002050J0L0N0n0r0{0|0÷h?hwOJQJh?h4OJQJh?h?OJQJh4OJQJmH sH h4OJQJh9CJOJPJQJaJ hYBhYBCJOJPJQJaJ)jhYBhYBCJOJPJQJUaJ8|000000%1E1V1W11111111^2_2h2i2k2l2222222_3`3l3m344444444J5K5R5S5U5V5555555?6@6L6M6667ȼ h9h9CJOJPJQJaJ)jh9h9CJOJPJQJUaJh.h95OJQJh95OJQJh?hOJQJh?hwOJQJh9h95OJQJh9hw5OJQJ;|001114 8:==c>n@o@z@ CEHIwIKKKzMKPgdCd7$8$H$gdwhgdsfcgd9gd9gd9gd?7777 88y8z88888888889q9r9}9~9::::::::E;F;N;O;Q;R;;;;;;;D<E<N<O<<<w=x=============U>ηh9h95OJQJh9hw5OJQJh?hwOJQJh4OJQJmH sH h?h?OJQJ h9h9CJOJPJQJaJ)jh9h9CJOJPJQJUaJ>U>V>>>S?T????@@@n@o@y@z@{@@@@@@@eAfAmAnApAqAAAAA`BaBBBBB C!CCCCCCCDDDDDDDDDDEEEEEEEEPFQFȳ h9h9CJOJPJQJaJ)jh9h9CJOJPJQJUaJh.h95OJQJh95OJQJhd%hOJQJ^Jh?hwOJQJh?hOJQJ@QFYFZF\F]FFFFFFFIGJGSGTGGGHHHHHIIIIIII IIIII!J"J#J*J+J,J/J0J6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH J`J Normal dCJ_HaJmH sH tH j`j $^ Heading 1d7$8$@&H$%5>*CJOJQJ\aJmHsHtHZZ `t Heading 3$<@&5CJOJPJQJ\^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List 6U`6 a0 Hyperlink >*B*phP>`P $^Title d5CJOJQJaJmHsHtH@/@ $^ Title Char5CJOJQJaJR/!R $^Heading 1 Char5>*CJOJQJ\^JaJ@ 2@ e\0Header  H$ mHsHtH6/A6 e\0 Header CharCJaJ@ `R@ e\0Footer  H$ mHsHtH6/a6 e\0 Footer CharCJaJvOrv ?Stop BSI$XP&d 7$8$H$P6_ (>*B*CJOJPJQJ^J_H aJph6_FOF ?Style1 dCJOJPJQJaJ** ? highlightRR `tHeading 3 Char5CJOJPJQJ\^JaJ\^\ `t0 Normal (Web)ddd[$\$CJOJPJQJaJP`P MpTOC 1 ' d5CJ OJPJQJaJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] xHv ***-* q %H*|07U>QFY>\>>>>I?S??@@CCCC DDDDDDME]EzEEEEhFsFvFFFGH*HxHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX $&-!8@0(  B S  ?anx FN?HtOUDIOWX_`d/< ai[hIV!&!0!8!N![!""F#N#######v%{%%%v&&&&&&&& ((8(<(_*e*`+i+++ ,,K-O---@.I.//z0|000r1z1338899::;;;;<<<<<<@@CC DDDDEEiFpFFFLHNHOHQHRHTHUHWHXHvHyH9:E+0-Ia148GMesv "'"4"8"$$&()(J({((((~),,//2222Q44x5z55555_6b6:;====@@@ADDiEmEE+GDGUG7H;HLHNHOHQHRHTHUHWHXHvHyH33333333333333333333333333333333333333333./@E_`aa  4;e|rs L(N(n(r((())))555555c6c6o899<<V?]?@AAAAAAAAwAwAAAAABB!B"B#B#B*B,B/B0BBBCDDFFKHLHXHsHyHU}'1&WG0S^M6T,N~y0=H[ ) h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJ QJ o(hHh8^8`OJQJo(hHh^`OJ QJ ^J o(hHoh ^ `OJ QJ o(hHh ^ `OJQJo(hHhx^x`OJ QJ ^J o(hHohH^H`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h^`OJQJo(hHh^`OJ QJ ^J o(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHohP^P`OJ QJ o(hHh8^8`OJQJo(hHh^`OJ QJ ^J o(hHoh ^ `OJ QJ o(hHh ^ `OJQJo(hHhx^x`OJ QJ ^J o(hHohH^H`OJ QJ o(hHh^`OJQJo(hHh^`OJ QJ ^J o(hHoh^`OJ QJ o(hHS^M=H[WG,NU}'                                             F+P4%N+OAG&N?b/PFPD=pl"/&3WoM l14aHS!ycC/mq 5L',+:P"<6v~J \ #i" J6 pL g#dY%P 6jE 5hu -l K9?+y" Pu#a u(' =5'.(v7@muP,YoSwHTXajtU>O)=Ez4lefxL7AI:5sIac[~YX;5* x\d>v7* )O`UL Cd M_{z" H@K^}!S!]gcB!H@K^!r/#J#=sG$A+.gX_%sgzR *%Nep~'?-u('[~=5'H(yD)d>B)XY*X&v* MK9?+(@~+ *%,+rX3,D)w&|-?-U%.#MKl"/GcC/&/?j0 *I(0p~'o 4 @,4xh[14qJ6jL,6+Hnv\8DM7AI:~qjYX;'< >;!/#ʶ=谿Ҵ)=>=>=J'< >j0:>,+tU>b&? ]w&/?{;R@sYN+OAVnCSA22|lA wz^S@B5h=Ev\8;{Ejb[ *IH/+IWoMpOGJU%.AHbJF6v~JUJ_N#MKIigDM%P WoMAHbJ#M=s_N sekNf`cb/Pq$[^@muPS:P&v*+PO)?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_abcdefgijklmnopqrstuvwxyz{|}~Root Entry FIZe1Table< GWordDocument7vSummaryInformation(`DocumentSummaryInformation8hHFCompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q